Business Context and Reporting Period
This Form 8-K filing by CareDx, Inc. (a Delaware corporation) reports a corporate governance event dated June 27, 2018. The filing announces the appointment of a new director to the Company's Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and associated compensation arrangements rather than financial performance.
Material Changes
The primary material change is the appointment of Amy Abernethy, M.D., Ph.D., as a Class I director, effective July 1, 2018. Dr. Abernethy will serve on the Science and Technology Committee and the Nominating and Corporate Governance Committee. She brings experience as the former Chief Medical Officer of Flatiron Health, Inc., and a former professor at Duke University School of Medicine.
Compensation and Governance Details
Dr. Abernethy's compensation package as a non-employee director includes:
- Cash Retainers: $35,000 annually for Board service, plus $5,000 annually for the Nominating and Corporate Governance Committee, and $5,000 annually for the Science and Technology Committee (paid quarterly).
- Initial Equity Grants: Stock options to purchase 30,000 shares (vesting monthly over three years) and 10,000 restricted stock units (vesting in three equal annual installments).
- Annual Automatic Grants: Options to purchase an additional 15,000 shares and 5,000 RSUs granted annually following the stockholder meeting.
The Company also entered into a standard indemnification agreement with Dr. Abernethy. No related party transactions or family relationships with existing directors or officers were disclosed.
Investor Verification Checklist
- Verify the commencement date of Dr. Abernethy's service (July 1, 2018) and her specific committee assignments.
- Confirm the vesting schedules for the initial 30,000 stock options and 10,000 RSUs.
- Review the Company's standard outside director compensation policy to understand the mechanics of the annual automatic grants (15,000 options and 5,000 RSUs).
- Check for any subsequent filings regarding the impact of this appointment on the Board's quorum or committee composition.